Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Navidea Biopharmaceuticals (NAVB)
OTHER OTC:NAVB
Holding NAVB?
Track your performance easily
NAVB Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range<$0.01 - $0.08
Previous Close$0.01
Volume2.08K
Average Volume (3M)N/A
Market Cap
$100.08K
Enterprise Value-$3.46M
Total Cash (Recent Filing)$3.86M
Total Debt (Recent Filing)$10.70K
Price to Earnings (P/E)―
Beta-67.06
Next Earnings
Nov 06, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.05
Shares Outstanding100,084,385
10 Day Avg. Volume9,218
30 Day Avg. VolumeN/A
Standard Deviation0.64
R-Squared0.01
Alpha0.03
Financial Highlights & Ratios
Price to Book (P/B)-0.03
Price to Sales (P/S)164.07
Price to Cash Flow (P/CF)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue-5.77K
Enterprise Value/Gross Profit20.33
Enterprise Value/Ebitda0.61
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Ownership Overview
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
NAVB FAQ
What was Navidea Biopharmaceuticals’s price range in the past 12 months?
Navidea Biopharmaceuticals lowest stock price was <$0.01 and its highest was $0.08 in the past 12 months.
What is Navidea Biopharmaceuticals’s market cap?
Currently, no data Available
When is Navidea Biopharmaceuticals’s upcoming earnings report date?
Navidea Biopharmaceuticals’s upcoming earnings report date is Nov 06, 2024 which is 16 days ago.
How were Navidea Biopharmaceuticals’s earnings last quarter?
Currently, no data Available
Is Navidea Biopharmaceuticals overvalued?
According to Wall Street analysts Navidea Biopharmaceuticals’s price is currently Overvalued.
Does Navidea Biopharmaceuticals pay dividends?
Navidea Biopharmaceuticals does not currently pay dividends.
What is Navidea Biopharmaceuticals’s EPS estimate?
Navidea Biopharmaceuticals’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Navidea Biopharmaceuticals have?
Navidea Biopharmaceuticals has 100,084,390 shares outstanding.
What happened to Navidea Biopharmaceuticals’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Navidea Biopharmaceuticals?
Currently, no hedge funds are holding shares in NAVB
---
Company Description
Navidea Biopharmaceuticals
Navidea Biopharmaceuticals, Inc. engages in the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. It operates through the following segments: Diagnostics, Therapeutics, and Corporate. The company was founded in 1983 and is headquartered in Dublin, OH.
---
NAVB Earnings Call
Q4 2023
0:00 / 0:00
---
---